Prostatectomía inmediata versus demorada en pacientes que progresan a una enfermedad de mayor riesgo en vigilancia activa

Translated title of the contribution: Immediate versus delayed prostatectomy and the fate of patients who progress to a higher risk disease on active surveillance

A. Mallya, V. Senguttuvan-Karthikeyan, A. Sivaraman, E. Barret, M. Galiano, N. Cathala, A. Mombet, D. Prapotnich, R. Sanchez-Salas, X. Cathelineau

Research output: Contribution to journalArticle

Abstract

Introduction: Oncological outcomes of radical prostatectomy (RP) in patients progressing on active surveillance (AS) are debated. We compared outcomes of AS eligible patients undergoing RP immediately after diagnosis with those doing so after delay or disease progression on AS. Methods: Between 2000 and 2014, 961 patients were AS eligible as per EAU criteria. RP within 6 months of diagnosis (IRP) or beyond (DRP), RP without AS (DRPa) and AS patients progressing to RP (DRPb) were compared. Baseline PSA, clinical and biopsy characteristics were noted. Oncological outcomes included adverse pathology in RP specimen and biochemical recurrence (BCR). Matched pair analysis was done between DRPb and GS7 patients undergoing immediate RP (GS7IRP). Results: IRP, DRP, DRPa and DRPb had 820 (85%), 141 (15%), 118 (12.24%) and 23 (2.7%) patients respectively. IRP, DRPa and DRPb underwent RP at a median of 3, 9 and 19 months after diagnosis respectively. Baseline characteristics were comparable. DRP vs. IRP had earlier median time (31 vs. 43 months; p<.001) and higher rate of progression to BCR (7.6 vs. 3.9%;p =.045). DRPb showed higher BCR (19 vs. 5%;p =.021) with earlier median time to BCR, compared to IRP and DRPa (p =.038). There was no difference in adverse pathology and BCR rates, but time to BCR was significantly lesser in DRPb (49 vs. 6 months;p<.001), compared to GS7IRP. Conclusions: Patients progressing on AS had worst oncological outcomes. RP for GS7 progression and matched pair of GS7 patients had similar outcomes. Worse oncological outcomes in AS progressors cannot be explained by a mere delay in RP.

Translated title of the contributionImmediate versus delayed prostatectomy and the fate of patients who progress to a higher risk disease on active surveillance
Original languageSpanish
Pages (from-to)324-330
Number of pages7
JournalActas Urologicas Espanolas
Volume43
Issue number6
DOIs
StatePublished - Jul 1 2019
Externally publishedYes

Keywords

  • Active surveillance
  • Delayed prostatectomy
  • Immediate prostatectomy
  • Progression
  • Prostate cancer

Fingerprint Dive into the research topics of 'Immediate versus delayed prostatectomy and the fate of patients who progress to a higher risk disease on active surveillance'. Together they form a unique fingerprint.

  • Cite this

    Mallya, A., Senguttuvan-Karthikeyan, V., Sivaraman, A., Barret, E., Galiano, M., Cathala, N., Mombet, A., Prapotnich, D., Sanchez-Salas, R., & Cathelineau, X. (2019). Prostatectomía inmediata versus demorada en pacientes que progresan a una enfermedad de mayor riesgo en vigilancia activa. Actas Urologicas Espanolas, 43(6), 324-330. https://doi.org/10.1016/j.acuro.2018.04.005